Member Info for Livedataaccount

Personally I wouldn't rule out a cohort 8 or 9

Alan is not one to rush things and if a higher does has a therapeutic value then it's worth carrying on. I wonder if they are doing more biopsies.

Avacta must be close to MTD, surely?

Avacta will be presenting at ASCO!!!!

Awsiting Hurstbot to give some info on this

Should be a big Monday!

Imo we are seeing heights capital still selling. And selling into weakness as positive news isn't imminent in terms of Aim. Mixed with a very retail based shareholder ownership. Avacta really needs some big investors onboard. Unfortunately the UK is a basket case at the moment.

Looking good for a massive summer here

Supply and demand.

Avacta need to attract some institutions to buy in.

Good news

Size buyers

Thry must be close now.

Is this going to be the longest phase 1 trial in history?

What number, Tim?

Gotta be close now, surely!

Good news.

It's not rocket science wyndrum.

The bondholders gets there allocated shares quarterly and sells them making a profit.

The share price is in a state of limbo as phase 1a has gone waaay over schedule and is now in de5 possibly into de6 with Alan stating there will be a short pause before going onto 1b.

It's 1b that will cause a big re rate (hopefully) when they measure against patients given dox only.

Hopefully up until this point avacta manage to woo some institutional investors

They should be nearing completion soon?

Come on Avacta, show us some leg.
About time the share price responded to the potential.

Harvey. Deadlines are usually such like around mid year, towards q4. Shortly or News will released only when Alan feels it's meaningful. Hope that helps

Are we close to MTD?

I would have thought its the financiers selling their recent share allocation.
Not ideal as need strength to sell into. If Alan wants to keep AVA6000 and 3396 how on earth is he going to finance it without hugely diluting the shares in issue? Will cost tens of millions to get them through all the stages

Great news